MediumEndocrinologyType 2 diabetes with cardiovascular diseaseau-racpau-amc
A 60-year-old woman with type 2 diabetes, BMI 30 kg/m² and a prior non-ST elevation myocardial infarction is taking maximally tolerated metformin. Her HbA1c is 8.1% (65 mmol/mol) despite lifestyle measures. According to contemporary Australian recommendations, which additional agent would be most appropriate to add?